Breast Cancer Clinical Trial
Official title:
Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations
The goal of this research study to learn about breast cancer survivorship and possible ways
to improve breast cancer survivorship programs using technology.
Objectives:
Objective 1: Assess breast cancer survivors on the acceptability of and preferences for the
integration of patient navigation and an eHealth technology platform to improve care in the
Survivorship Clinic at Lyndon B. Johnson Hospital.
Objective 2: Assess clinic stakeholders acceptability of and preferences for the integration
of patient navigation and an eHealth technology platform to improve care for breast cancer
patients in the Survivorship Clinic at Lyndon B. Johnson Hospital.
Breast Cancer Survivors:
If patient agrees to take part in this study, they will visit the cancer survivorship clinic
where the following tests and procedures will be performed:
- Patient will have a 30-60 minute interview where they will be asked about cancer-related
informational needs, feelings about survivorship care plans, and preferred methods of
communication with survivorship clinic staff.
- Patient will be asked about whether they would use the internet and other technologies
(such as text messages for appointment reminders) as tools in breast cancer
survivorship.
- Patient will use a web-based tool called HealthATM. HealthATM is a website that is
designed to provide information and tools to help patients better manage their health.
After 10-15 minute session with the website, patient will be asked about how easy the
website was to use and other questions about their session.
- Patient will complete a short questionnaire at the end of the interview asking about
personal characteristics, how involved they are in their health care, and their
attitudes towards the HealthATM website. It should take about 5 minutes to complete this
questionnaire.
All interviews will be audiorecorded. All audio recordings will be kept for 5 years and then
destroyed. All interview data will be stored in password-protected computers and/or locked
file cabinets. There will be no personal identifying information connected to patient's
interview answers.
Length of Study:
All of the study procedures will take place at one visit. The visit should last about 60
minutes.
This is an investigational study.
Up to 40 participants will be enrolled in this study. All will be enrolled at LBJ General
Hospital.
Clinic Stakeholders:
If clinic staff agree to take part in this study, the following tests and procedures will be
performed:
- Clinic staff will take part in a 60-90 minute focus group session where they will be
asked about their feelings about survivorship care plans and if they think web-based
eHealth programs would be helpful as tools in breast cancer survivorship.
- Clinic staff will be asked about any challenges and barriers they feel are facing the
survivorship programs at LBJ.
- Clinic staff will use a web-based tool called HealthATM. HealthATM is a website that
provides information and tools to help patients better manage their health. After a
10-15 minute session with the website, they will be asked about how easy the website was
to use and other questions about their session.
All focus group sessions will be audiorecorded. All audio recordings will be kept for 5 years
and then destroyed. All focus group data will be stored in password-protected computers
and/or locked file cabinets. There will be no personal identifying information connected to
your focus group answers.
Length of Study:
All of the study procedures will take place at one visit. The visit should last about 60
minutes.
This is an investigational study.
Up to 40 stakeholders will be enrolled in this study. All will be enrolled at LBJ General
Hospital.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |